|
1
|
American Cancer Society. Cancer Facts and
Figures. Atlanta, GA: American Cancer Society; 2009, http://www.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2009/index.
|
|
2
|
Mandić A, Tešić M, Vujkov T, Novta N and
Rajović J: Ovarian cancer stage III/IV: poor prognostic factors.
Arch Oncol. 9:13–16. 2001.
|
|
3
|
Li Z, Zhao X, Yang J and Wei Y: Proteomics
profile changes in cisplatin-treated human ovarian cancer cell
strain. Sci China C Life Sci. 48:648–657. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
De Marco C, Rinaldo N, Bruni P, et al:
Multiple genetic alterations within the PI3K pathway are
responsible for AKT activation in patients with ovarian carcinoma.
PLoS One. 8:e553622013.PubMed/NCBI
|
|
5
|
Okuda T and Kondoh H: Identification of
new genes Ndr2 and Ndr3 which are related to
Ndr1/RTP/Drg1 but show distinct tissue specificity and
response to N-myc. Biochem Biophys Res Commun. 266:208–215.
1999.
|
|
6
|
Zhou D, Salnikow K and Costa M:
Cap43, a novel gene specifically induced by Ni2+
compounds. Cancer Res. 58:2182–2189. 1998.
|
|
7
|
Angst E, Dawson DW, Stroka D, et al: N-myc
downstream regulated gene-1 expression correlates with reduced
pancreatic cancer growth and increased apoptosis in vitro and in
vivo. Surgery. 149:614–624. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Maruyama Y, Ono M, Kawahara A, et al:
Tumor growth suppression in pancreatic cancer by a putative
metastasis suppressor gene Cap43/NDRG1/Drg-1 through
modulation of angiogenesis. Cancer Res. 66:6233–6242. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bandyopadhyay S, Pai SK, Hirota S, et al:
Role of the putative tumor metastasis suppressor gene Drg-1 in
breast cancer progression. Oncogene. 23:5675–5681. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bandyopadhyay S, Pai SK, Gross SC, et al:
The Drg-1 gene suppresses tumor metastasis in prostate
cancer. Cancer Res. 63:1731–1736. 2003.
|
|
11
|
Kovacevic Z, Sivagurunathan S, Mangs H,
Chikhani S, Zhang D and Richardson DR: The metastasis suppressor,
N-myc downstream regulated gene 1 (NDRG1), upregulates p21 via
p53-independent mechanisms. Carcinogenesis. 32:732–740. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu W, Iiizumi-Gairani M, Okuda H, et al:
KAI1 gene is engaged in NDRG1 gene-mediated
metastasis suppression through the ATF3-NFκB complex in human
prostate cancer. J Biol Chem. 286:18949–18959. 2011. View Article : Google Scholar
|
|
13
|
Hosoi F, Izumi H, Kawahara A, et al: N-myc
downstream regulated gene 1/Cap43 suppresses tumor growth and
angiogenesis of pancreatic cancer through attenuation of inhibitor
of κB kinase β expression. Cancer Res. 69:4983–4991.
2009.PubMed/NCBI
|
|
14
|
Zhao G, Chen J, Deng Y, et al:
Identification of NDRG1-regulated genes associated with invasive
potential in cervical and ovarian cancer cells. Biochem Biophys Res
Commun. 408:154–159. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li Q and Chen H: Transcriptional silencing
of N-Myc downstream-regulated gene 1 (NDRG1) in metastatic colon
cancer cell line SW620. Clin Exp Metastasis. 28:127–135. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jiang K, Shen Z, Ye Y, Yang X and Wang S:
A novel molecular marker for early detection and evaluating
prognosis of gastric cancer: N-myc downstream regulated gene-1
(NDRG1). Scand J Gastroenterol. 45:898–908. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yan X, Chua MS, Sun H and So S: N-Myc
down-regulated gene 1 mediates proliferation, invasion, and
apoptosis of hepatocellular carcinoma cells. Cancer Lett.
262:133–142. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cheng J, Xie HY, Xu X, et al: NDRG1 as a
biomarker for metastasis, recurrence and of poor prognosis in
hepatocellular carcinoma. Cancer Lett. 310:35–45. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zou H, Wang D, Gan X, et al: Low TWEAK
expression is correlated to the progression of squamous cervical
carcinoma. Gynecol Oncol. 123:123–128. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen S, Han YH, Zheng Y, et al: NDRG1
contributes to retinoic acid-induced differentiation of leukemic
cells. Leuk Res. 33:1108–1113. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kalaydjieva L, Gresham D, Gooding R, et
al: N-myc downstream-regulated gene 1 is mutated in
hereditary motor and sensory neuropathy-Lom. Am J Hum Genet.
67:47–58. 2000. View
Article : Google Scholar
|
|
22
|
Kovacevic Z and Richardson DR: The
metastasis suppressor, Ndrg-1: a new ally in the fight against
cancer. Carcinogenesis. 27:2355–2366. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lv XH, Chen JW, Zhao G, et al: N-myc
downstream-regulated gene 1/Cap43 may function as tumor suppressor
in endometrial cancer. J Cancer Res Clin Oncol. 138:1703–1715.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang J, Cai J, Li Z, et al: Expression and
biological function of N-myc down-regulated gene 1 in human
cervical cancer. J Huazhong Univ Sci Technolog Med Sci. 30:771–776.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu YL, Bai WT, Luo W, et al:
Downregulation of NDRG1 promotes invasion of human gastric cancer
AGS cells through MMP-2. Tumour Biol. 32:99–105. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fotovati A, Abu-Ali S, Kage M, Shirouzu K,
Yamana H and Kuwano M: N-myc downstream-regulated gene 1 (NDRG1) a
differentiation marker of human breast cancer. Pathol Oncol Res.
17:525–533. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tsui KH, Chang YL, Feng TH, Chang PL and
Juang HH: Glycoprotein transmembrane nmb: an androgen-downregulated
gene attenuates cell invasion and tumorigenesis in prostate
carcinoma cells. Prostate. 72:1431–1442. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Akiba J, Murakami Y, Noda M, et al: N-myc
downstream regulated gene1/Cap43 overexpression suppresses tumor
growth by hepatic cancer cells through cell cycle arrest at the
G0/G1 phase. Cancer Lett. 310:25–34. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gurova KV, Rokhlin OW, Budanov AV, et al:
Cooperation of two mutant p53 alleles contributes to Fas
resistance of prostate carcinoma cells. Cancer Res. 63:2905–2912.
2003.PubMed/NCBI
|
|
30
|
Campomenosi P, Monti P, Aprile A, et al:
p53 mutants can often transactivate promoters containing a
p21 but not Bax or PIG3 responsive elements.
Oncogene. 20:3573–3579. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
el-Deiry WS, Harper JW, O’Connor PM, et
al: WAF1/CIP1 is induced in p53-mediated
G1 arrest and apoptosis. Cancer Res. 54:1169–1174.
1994.
|
|
32
|
Elbendary AA, Cirisano FD, Evans AC Jr, et
al: Relationship between p21 expression and mutation of the p53
tumor suppressor gene in normal and malignant ovarian epithelial
cells. Clin Cancer Res. 2:1571–1575. 1996.PubMed/NCBI
|
